FDA Adverse Event Malfunction Summary report: N

TARGIS SYSTEM

MDR report key: 2033401 · Received March 22, 2011

Report

Report Number
2133936-2011-00008
Event Type
Malfunction
Date Received
March 22, 2011
Date of Event
February 22, 2011
Report Date
March 22, 2011
Manufacturer
UROLOGIX, INC.
Product Code
MEQ
PMA / PMN Number
P970008
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE CATHETER WAS RETURNED FOR ANALYSIS. THE LOCATION BALLOON WAS INFLATED WITH 10CC'S OF WATER. UPON VISUAL INSPECTION, WATER WAS OBSERVED LEAKING FROM THE HANDLE AREA WHERE THE EXTRUSION AND THE STRAIN RELIEF MEET. THE DEVICE HISTORY RECORD FOR THE CATHETER WAS REVIEWED; ALL MFG AND QUALITY ASSURANCE TESTING WAS CARRIED OUT IN ACCORDANCE WITH STANDARD PROCEDURES, AND THE DEVICE MET SPECIFICATIONS AT THE TIME OF RELEASE. IN ADDITION, THE LOCATION BALLOON WAS TESTED IN ACCORDANCE WITH APPROVED PROTOCOL BEFORE BEING INSERTED INTO THE PT; NO ISSUES WERE DETECTED DURING TESTING. THE LOCATION BALLOON WOULD NOT REMAIN INFLATED DUE TO THE LEAK IN THE HANDLE PORTION OF THE DEVICE. HOWEVER, THE ROOT CAUSE OF THE LEAK IN THE HANDLE REMAINS UNK.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE CATHETER LOCATION BALLOON WOULD NOT REMAIN INFLATED DURING A TRANSURETHRAL MICROWAVE TREATMENT. THE PHYSICIAN INSERTED THE CATHETER W/O ANY ISSUES. WHEN THE PHYSICIAN ATTEMPTED TO INFLATE THE LOCATION BALLOON WITH STERILE WATER, WATER WAS OBSERVED LEAKING THROUGH THE CATHETER HANDLE. THE LOCATION BALLOON WAS ALSO TESTED IN ACCORDANCE WITH APPROVED PROTOCOL BEFORE BEING INSERTED INTO THE PT; NO ISSUES WERE DETECTED DURING TESTING. THE LOCATION BALLOON MALFUNCTION OCCURRED PRIOR TO ENERGY DELIVERY TO THE CATHETER. NO PT INJURIES OR COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TARGIS SYSTEM MICROWAVE DELIVERY SYSTEM MEQ UROLOGIX, INC. 4000A 101103MHA1

Patients

Seq Age Sex Outcome Treatment
1